Steven Enderby
Executive Director / CEO
pharmaceutical
Hemas Pharmaceuticals Pvt. Ltd.
Sri Lanka
Biography
Mr. Steven Enderby joined Hemas in March 2013 to head the Group’s efforts in Mergers and Acquisitions. He took up the Office of Deputy CEO and Director of Hemas Holdings PLC in November 2013 and was appointed the Chief Executive Officer of the Company on 01st April 2014. Mr. Enderby has had a successful track record in the private equity space with Actis, a leading global emerging markets fund, until his retirement in 2011 as an Actis Partner. Some of the most successful private equity transactions he led include South Asia Gateway Terminal, Ceylon Oxygen and Millennium Information Technologies. He has also served on the Boards of leading companies in Sri Lanka and India such as John Keells Holdings, Lion Brewery and Punjab Tractors. He is a Fellow of the Chartered Institute of Management Accountants, and holds a Degree in Economics and Accounting from Queens University Belfast, and a Master’s Degree in Development Studies from the University of Melbourne.
Research Interest
pharmaceutical science